细胞质多化元素结合蛋白1在瘤发生中的作用
JiaYi Li1,2,3, Yinxin Wu1,2,3, Dingyin Zhang1,2,3
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University.
Mini reviews in medicinal chemistry
|June 16, 2024
概括
细胞质多基化元素结合蛋白1 (CPEB1) 在各种癌症中充当瘤抑制剂和促进剂. 它的双重作用凸显了其作为瘤学中的预后指标和治疗目标的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- CPEB1是一种聚氨基化结合蛋白,通过与细胞质聚氨基化元素 (CPE) 结合,影响mRNA和蛋白质的表达.
- 异常的CPEB1表达与多种癌症类型的瘤发生有关.
- 本综述探讨了CPEB1在癌症发展中的多方面的作用.
研究的目的:
- 审查和总结CPEB1在各种癌症中的功能和机制.
- 解剖CPEB1对特定恶性瘤的发病和进展的影响.
- 建议未来的治疗方向涉及CPEB1.1.
主要方法:
- 对95件符合条件的产品进行系统审查.
- 分析的重点是CPEB1与质母细胞瘤,乳腺癌,肝细胞癌,胃癌,结直肠癌,非小细胞肺癌,前列腺癌和黑色素瘤的关联.
- 评估研究质量和与CPEB的关联力1.1.
主要成果:
- 在乳腺,子宫内膜,肝细胞,非小细胞肺癌,前列腺癌和黑色素瘤中,CPEB1充当瘤抑制剂.
- 在质母细胞瘤,胃癌和结直肠癌中,CPEB1表现出双重作用,促进或抑制瘤发生.
- 在不同类型的癌症中,CPEB1的表达模式在不同类型的癌症中存在显著差异.
结论:
- 在瘤学中,CPEB1显示出作为治疗标和预后生物标记物的潜力.
- 它在亡,增殖,迁移,入侵,茎状,耐药性和铁亡中的功能与癌症有关.
- CPEB1的动态检测指数可能有助于癌症管理.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


